The conviction of Merck laboratory by first instance court and imposition of a 253 million USD-payment in damages and interests for the anti-inflammatory Vioxx deemed hazardous raised serious concerns among business professionals over the coverage of risks pertaining to the pharmaceutical industry.
Links:
[1] https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.atlas-mag.net%2Fen%2Farticle%2Fthe-coverage-of-the-pharmaceutical-industry-risks-is-of-concern-to-insurers&text=The+coverage+of+the+pharmaceutical+industry+risks+is+of+concern+to+insurers
[2] https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.atlas-mag.net%2Fen%2Farticle%2Fthe-coverage-of-the-pharmaceutical-industry-risks-is-of-concern-to-insurers&source=Atlas Magazine&mini=true
[3] https://www.atlas-mag.net/en/issue/a-devastating-summer